scholarly journals Small-Cell Carcinoma of the Uterine Cervix Discovered With Quadriplegia Caused by Cervical Spine Metastasis

2020 ◽  
Vol 13 ◽  
pp. 117954762092017
Author(s):  
Tomoko Oishi ◽  
Masakazu Nishida ◽  
Kanetoshi Takebayashi ◽  
Kaei Nasu ◽  
Hisashi Narahara

Small-cell carcinoma of the uterine cervix is a rare and aggressive tumor, and the prognosis is poor compared with those of squamous cell carcinoma and adenocarcinoma of the uterine cervix, even when discovered at an earlier stage. We treated a patient with progressive small-cell carcinoma of the uterine cervix that metastasized to the cervical spine. The patient, a 73-year-old woman, presented with the symptom of numbness in her limbs. As she had difficulty moving her limbs (ie, quadriplegia), she was carried to an emergency room. A metastatic cervical spine tumor from the uterine cervical cancer was revealed by a computed tomography scan, and the patient was then transferred to our hospital’s neurosurgery department for treatment. We performed a resection of the cervical spine tumor and fixation of the spinal bone. Because the patient’s performance status was 4 and she remained bedridden 24 h/day, we could not perform systemic chemotherapy. We thus provided palliative care, including palliative radiotherapy, pain control, and rehabilitation to improve her limbs’ functioning. The patient died of the uterine cancer within approx. 6 months after the initiation of treatment. There is no established treatment for small-cell carcinoma as a gynecological lesion. For patients with progressive uterine cancer, the optimal treatments, including palliative care, must be determined.

2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Mawuli F. Attipoe ◽  
Charles D. Sturgis

Definitive cytomorphologic diagnosis of small cell carcinoma of the uterine cervix is possible but can be challenging in routine cervicovaginal cancer screening specimens. Several small series of reported cases of cervical small cell carcinoma have shown this uncommon malignancy to represent fewer than 2% of all invasive cervical cancers. This tumor type is associated with poor prognosis and rapid disease progression and can develop to an advanced stage in the interval between screening visits. Only rare case reports of small cell carcinoma arising in gravid cervices are known. In the current case a 29-year-old, gravida 6, para 2, pregnant (10-week gestation) female presented with postcoital bleeding. A definitive diagnosis of small cell carcinoma of the cervix was made possible by liquid based Pap testing with ancillary cell block preparation allowing for immunocytochemical characterization of the lesional cell population.


2012 ◽  
Vol 2 (1) ◽  
Author(s):  
Aymen Lagha ◽  
Nadia Bouzid ◽  
Samia Kanoun Belajouza ◽  
Soumaya Labidi ◽  
Asma Saiidi ◽  
...  

1994 ◽  
pp. 479-481
Author(s):  
T. C. Chang ◽  
H. C. Chang ◽  
C. H. Lai ◽  
S. Hsueh ◽  
S. F. Huang ◽  
...  

2003 ◽  
Vol 34 (8) ◽  
pp. 778-783 ◽  
Author(s):  
Nobuo Masumoto ◽  
Takuma Fujii ◽  
Mitsuya Ishikawa ◽  
Miyuki Saito ◽  
Takashi Iwata ◽  
...  

2020 ◽  
Vol 13 (1) ◽  
pp. 373-378 ◽  
Author(s):  
Yuri Nakao ◽  
Satoshi Tamauchi ◽  
Nobuhisa Yoshikawa ◽  
Shiro Suzuki ◽  
Hiroaki Kajiyama ◽  
...  

We report a case of recurrent small cell carcinoma of the uterine cervix that showed a complete response to paclitaxel, carboplatin, and bevacizumab (TC + Bev) combination therapy. Small cell carcinoma of the uterine cervix is extremely rare, with an incidence of only 1.3% in Japan, and a poor outcome. The patient was a 62-year-old woman with a chief complaint of irregular vaginal bleeding. Magnetic resonance imaging showed a 10-cm irregular mass from the uterine corpus’s posterior wall to the cervix. Abdominal total hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymph node sampling were performed for suspected uterine sarcoma. Histopathological findings revealed small cell carcinoma with lymph node metastasis. Although 6 cycles of etoposide + cisplatin were performed, para-aortic lymph node recurrence was found 3 months after chemotherapy. Subsequently, the patient received 8 cycles of TC + Bev, which eliminated the metastases. The patient is currently alive at 24 months.


Oncology ◽  
2001 ◽  
Vol 60 (4) ◽  
pp. 367-372 ◽  
Author(s):  
Yasushi Saga ◽  
Mitsuaki Suzuki ◽  
Natsuko Tamura ◽  
Michitaka Ohwada ◽  
Ikuo Sato

1997 ◽  
Vol 30 (4) ◽  
pp. 202-208 ◽  
Author(s):  
Hidetaka Katabuchi ◽  
Hideyuki Ohtake ◽  
Hironori Tashiro ◽  
Yoshito Suenaga ◽  
Akihiro Ohshige ◽  
...  

2010 ◽  
Vol 12 (7) ◽  
pp. 512-513 ◽  
Author(s):  
Anna Reig Castillejo ◽  
Ismael Membrive Conejo ◽  
Palmira Foro Arnalot ◽  
Nuria Rodríguez de Dios ◽  
Manuel Algara López

1996 ◽  
Vol 6 (5) ◽  
pp. 369-375 ◽  
Author(s):  
C. Faul ◽  
S. Kounelis ◽  
K. Karasek ◽  
H. Papadaki ◽  
J. Greenberger ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document